You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《股海通胜》 石药倒升吼12838购 腾讯硬净吼65407牛
阿思达克 11-11 14:27

特朗普称贸谈进展慢於预期且未承诺撤回现有关税,加之本港周末及今晨(11号)本地事件冲突升级,恒指今大幅低开289点後一度急跌逾600点失守250天线,暂时於27000点关口徘徊。恒指半日收跌581点,报27071点。投资者若看好可留意恒指牛证63825,收回价26797点,杠杆约73倍,换股比率10000:1。看淡或对冲留意恒指熊证66282,收回价27418点,杠杆约54倍,换股比率10000:1。

恒指大跌下,石药(01093)一枝独秀升近1.5%。石药近月来沿着5天线上行,亦陆续获大行上调目标价,认为公司加大对创新药物的长期增长投入策略,有助公司未来创新产品周期的布局。续看好留意石药购证12838,行使价22.8元,实际杠杆3.99倍,到期日20年5月。

腾讯(00700)将於周三公布季续,今日表现硬净,现微跌不足1%。消息方面腾讯寻求与日本任天堂合作开发switch主机游戏,旨在进一步扩展其北美业务。数据分析公司Sensor Tower称腾讯10月份於海外上线的“使命召唤”系列下载量登顶达1.48亿次,约为腾讯带来5300万美元的收入。投资者看好可留意腾讯牛证65407,收回价318.4元,实际杠杆25.26倍,到期日20年3月。续看淡可留意腾讯熊证56403,收回价338.8元,实际杠杆17.8倍,到期日20年4月。

《海通国际股票衍生产品部》

请参阅:www.htiwarrants.com

注:本资料之内容由从事证券及期货条例(Cap.571)中第一类(证券交易)及第四类(就证券提供意见)受规管活动之持牌法团–海通国际证券有限公司(「海通国际 )所编制及发行,唯并不代表资料内容已获香港证券及期货事务监察委员会审批。本资料的任何内容仅供参考,并不构成对任何投资买卖的邀请或招揽、建议或推荐。结构性产品如认股证及/或牛熊证的价格可跌可升,过往的表现并非未来表现的指标。结构性产品的价值可在到期时或到期前变成零,投资者因而引致投资全盘损失。牛熊证设有强制收回机制,因此有可能提早终止,在此情况下(i)N类牛熊证投资者会损失於牛熊证的全部投资;而(ii)R类牛熊证之剩证之剩余价值则可能为零。由海通国际或其联属公司所发行的结构性产品是没有相应抵押品,投资者应当自行留意发行商的偿债能力,以判断发行商是否有能力履行其所发行的结构性产品内应负之责任和义务。如发行人无力偿债或违约,投资者可能无法收回部份或全部应收款项。投资前,投资者应仔细参阅认股证及/或牛熊证的有关上市档(及任何该档之附录)及有关补充上市档所载的详情(包括风险因素),充份了解产品的性质及风险,考虑投资是否适合投资者的个别情况,如有需要,应谘询专业顾问。海通国际为本资料提及之证券的认股证及/或牛熊证(「结构性产品」)之流通量提供者,亦可能是唯一在交易所为结构性产品提供买卖报价的一方, 因此结构性产品之第二市场可能有限。海通国际(连同其附属及其联属公司,统称「海通国际集团」)真诚努力确保所提供资料正确和完整,惟海通国际集团并不保证该等资料的完整性及准确性,亦不对任何资料的不准确或遗漏负上任何责任。海通国际证券有限公司乃海通国际证券集团成员并因此同属於海通证券股份有限公司。海通国际证券有限公司为此文提及之证券及/或该证券的衍生产品进行庄家活动。~重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account